Thermo Fisher Scientific Inc (TMO)
Thermo Fisher Scientific Inc (TMO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 2,125 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,414 | 3,723 | 1,251 | 1,960 | 2,166 | 3,290 | 723 | 1,399 | 2,239 | 3,457 | 1,192 | 2,125 | 9,013 | |
| 853 | 839 | 836 | 790 | 740 | 740 | 706 | 685 | 662 | 728 | 736 | 816 | 2,942 | |
| -150 | 61 | 70 | 84 | 68 | 79 | 75 | 81 | 70 | 84 | 83 | – | – | |
| -145 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -9.0 | 1,723 | -787 | -216 | 30 | 594 | -1,425 | -726 | 2,151 | 489 | -1,112 | 1,112 | 2,640 | |
| 332 | 405 | 347 | 301 | 272 | 480 | 362 | 294 | 404 | 465 | 376 | 450 | 1,695 | |
| -4,766 | -376 | -2,030 | -253 | -3,578 | 20 | -527 | -288 | -4,123 | 891 | -8,961 | 164 | -12,029 | |
| 135 | 136 | 135 | 149 | 150 | 149 | 149 | 162 | 163 | 162 | 162 | 175 | 662 | |
| -3,000 | 0.0 | -3,000 | 0.0 | -3,000 | -1,000 | -2,000 | -2,000 | 2,000 | -3,000 | -3,000 | -1,000 | -5,000 | |
| 1,972 | – | – | – | -1,107 | -2,500 | 2,002 | -787 | 498 | 3,634 | 4,215 | – | – | |
| 1,855 | -1,428 | -1,821 | -114 | -1,190 | -3,666 | -102 | -991 | -632 | 3,526 | 1,093 | -2,571 | 1,416 | |
| 3,015 | 1,929 | -2,577 | 1,578 | -2,427 | -630 | 131 | 431 | -2,592 | 7,868 | -6,599 | -183 | -1,506 | |
| 2,082 | 3,318 | 904 | 1,659 | 1,894 | 2,810 | 361 | 1,105 | 1,835 | 2,992 | 816 | 1,675 | 7,318 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.